Уноси
Search full-text
"Jelena Jovanić"
-
Significance of ER, PR and HER2 receptor for the occurrence of metastases in breast cancer. Whether certain subtypes frequently metastasized to the lungs (Предиктивни значај ER, PR и HER2 рецептора за појаву метастаза карцинома дојке, да ли поједини подтипови чешће метастазирају у плућа?) (2014)
M. Vještica, Z. Gojković, I. Rakita, S. Jungić, A. Guzijan, J. Jovanić, R. Rašeta, S. Lekić, J. Rožić, Significance of ER, PR and HER2 receptor for the occurrence of metastases in breast cancer. Whether certain subtypes frequently metastasized to the lungs (Предиктивни значај ER, PR и HER2 рецептора за појаву метастаза карцинома дојке, да ли поједини подтипови чешће метастазирају у плућа?), Respiratio vol 4, br 1-2, pp. 52 - 55, 2014 -
Realizing the therapeutic potential of novel cardioprotective therapies: The EU-CARDIOPROTECTION COST Action - CA16225 (2018-04)
I. Andreadou, P. Adamovski, M. Bartekova, C. Beauloye, L. Bertrand, D. Biedermann, V. Borutaite, H. Erik Botker, M. Dambrova, S. Chlopicki, Y. Devaux, S. Davidson, F. Di Lisa, D. Djuric, D. Erlinge, I. Falcao-Pires, E. Galatou, D. Garcia-Dorado, A. Garcia-Sosa, H. Girao, M. Gyongyosi, Z. Giricz, D. Healy, G. Heusch, V. Jakovljevic, J. Jovanic, F. Kolar, B. Kwak, P. Leszek, E. Liepnish, S. Longnus, J. Marinovic, D. Muntean, L. Nežić, M. Ovize, P. Paglliaro, C. Pedrosa da Costa Gomes, J. Pernow, A. Persidis, S. Pischke, B. Podesser, F. Prunier, T. Ravingerova, M. Ruiz-Meana, R. Schulz, A. Scridon, K. Slagsvold, J. Lonborg, B. Turan, N. van Royen, M. Vendelin, S. Walsh, D. Yellon, N. Zidar, C. Zuurbier, P. Ferdinandy, D. Hausenloy, Realizing the therapeutic potential of novel cardioprotective therapies: The EU-CARDIOPROTECTION COST Action - CA16225, Conditioning medicine, Vol. 1, No. 3, pp. 116 - 123, Apr, 2018 -
Patients perspectives on drug shortages in six European hospital settings – a cross sectional study (2021)
Kuruc Poje D, Kifer D, Huys I, Miranda J, Jenzer H, Miljković N, Hoppe- Tichy T, Bochniarz M, Frotini R, Schwartz D, Vujić- Aleksić V, Nezic L, Rinaki E, Tzimis L, Green K, Jovanic J, Caric B, Mandic D, Vilic K, Bochenek T, Baciv Vrca V, Marusic S, Patients perspectives on drug shortages in six European hospital settings – a cross sectional study, BMC HEALTH SERVICES RESEARCH, pp. 1 - 10, 2021 -
The effect of myoinositol and metformin on cardiovascular risk factors in women with polycystic ovary syndrome: a randomized controlled trial (2021-06)
V. Soldat-Stanković, S. Popović-Pejičić, S. Stanković, J. Jovanić, J. Bjekić-Macut, S. Livadas, S. Ognjanović, G. Mastorakos, D. Micić, Đ. Macut, The effect of myoinositol and metformin on cardiovascular risk factors in women with polycystic ovary syndrome: a randomized controlled trial, ACTA ENDOCRINOLOGICA-BUCHAREST, Vol. 17, No. 2, pp. 241 - 247, Jun, 2021 -
Patients perspectives on drug shortages in six European hospital settings – a cross sectional study (2021-07)
D. Kuruc Poje, D. Kifer, I. Huys, J. Miranda, H. Jenzer, N. Miljković, T. Hoppe-Tichy, M. Bochniarz, R. Frontini, D. Schwartz, V. Vujić-Aleksić, L. Nežić, E. Rinaki, L. Tzimis, T. Green, J. Jovanić, B. Carić, D. Mandić, K. Vilić, T. Bochenek, V. Bačić Vrca, S. Marušić, Patients perspectives on drug shortages in six European hospital settings – a cross sectional study, BMC HEALTH SERVICES RESEARCH, Vol. 21, No. 689, Jul, 2021 -
Klinička prezentacija Marfanov sindrom – prikaz slučaja. (2012)
J. Jovanić, T. Kovačević-Preradović, V. Katić, B. Goronja, N. Dobrijević, L. Kos, D. Smiljanić, M. Šobot, S. Srdić, Klinička prezentacija Marfanov sindrom – prikaz slučaja., Zbornik radova i sažetaka III Kongresa kardiologa Republike Srpske sa međunarodnim učešćem 2012;68., 2012 -
Кarcinom želuca i celijakija – prikaz slučaja (2020)
A. Figurek, M. Vještica, Z. Gojković, J. Jovanić, S. Jungić, P. Dašić, Кarcinom želuca i celijakija – prikaz slučaja, Zbornik apstrakata, godina 4. broj 1, 2020 -
Science Communications Manager, EU-Cardioprotection COST Action Ca-16225 (2017-10)
J. Jovanić, Science Communications Manager, EU-Cardioprotection COST Action Ca-16225, Oct, 2017 -
Science Communications Manager, EU COST Innovators grant (CIG), Improving Preclinical Assessment of Cardioprotective therapies-IG 16225 network (2022-10)
J. Jovanić, Science Communications Manager, EU COST Innovators grant (CIG), Improving Preclinical Assessment of Cardioprotective therapies-IG 16225 network, Oct, 2022 -
COST Action Management Committee-European network to tackle Metabolic alterations in heart failure (EU-METAHEART) (2023-10)
J. Jovanić, COST Action Management Committee-European network to tackle Metabolic alterations in heart failure (EU-METAHEART), Oct, 2023 -
COST Action CA 21153-Network for implementing multiomics approaches in atherosclerotic cardiovascular disease prevention and research (AtheroNET)- Member of working group 1. and 2. WG1-Pathophysiological mechanisms in atherosclerosis WG 2- Personalized models for clinical applications in ASCVD (2023-10)
J. Jovanić, COST Action CA 21153-Network for implementing multiomics approaches in atherosclerotic cardiovascular disease prevention and research (AtheroNET)- Member of working group 1. and 2. WG1-Pathophysiological mechanisms in atherosclerosis WG 2- Personalized models for clinical applications in ASCVD, Oct, 2023 -
Uticaj prethodnog bronhološkog oboljenja na dužinu preživljavanja žena sa karcinomom pluća o bronha (2011-11)
J. Jovanić, Uticaj prethodnog bronhološkog oboljenja na dužinu preživljavanja žena sa karcinomom pluća o bronha, Nov, 2011 -
Contrast induced nephropathy- case report (2012-05)
J. Jovanić, Contrast induced nephropathy- case report, May, 2012 -
Karakteristike karcinoma pluća kod žena u Republici Srpskoj (2012-05)
J. Jovanić, Karakteristike karcinoma pluća kod žena u Republici Srpskoj, May, 2012 -
Klinička prezentacija Marfanov sindrom-prikaz slučaja (2012-06)
J. Jovanić, Klinička prezentacija Marfanov sindrom-prikaz slučaja, Jun, 2012 -
Trombotske mase i novi oralni antikoagulansi kao terapijske opcije-prikaz slučaja (2013-05)
J. Jovanić, Trombotske mase i novi oralni antikoagulansi kao terapijske opcije-prikaz slučaja, May, 2013 -
Dva različita klinička završetka-prikaz slučaja infektivnog endokarditisa (2013-05)
J. Jovanić, Dva različita klinička završetka-prikaz slučaja infektivnog endokarditisa, May, 2013 -
Prognostički značaj HbA1c kod pacijentice sa akutnim infarktom miokarda i novootkrivenim dijabetes melitusom (2013-05)
J. Jovanić, Prognostički značaj HbA1c kod pacijentice sa akutnim infarktom miokarda i novootkrivenim dijabetes melitusom, May, 2013 -
Trostruko negativan karcinom dojke kao tumor primarno nepoznatnog porijekla-prikaz slučaja (2014-11)
J. Jovanić, Trostruko negativan karcinom dojke kao tumor primarno nepoznatnog porijekla-prikaz slučaja, Nov, 2014 -
Prevention and intervention in cardiology (2017-10)
J. Jovanić, Prevention and intervention in cardiology, Oct, 2017